diagnosis schizophrenia psychotic disorder based criteria either american psychiatric associations diagnostic statistical manual mental disorders world health organizations international classification diseases clinical assessment schizophrenia carried mental health professional based observed behavior reported experiences reports others familiar diagnosis usually made associated symptoms occur along continuum population must reach certain severity level impairment diagnosis schizophrenia prevalence rate united states american psychiatric association released fifth edition dsm according manual diagnosed schizophrenia two diagnostic criteria met much time period least one month significant impact social occupational functioning least six months dsm diagnostic criteria outlines person experiencing either delusions hallucinations disorganized speech words individual experiencing delusions hallucinations receive diagnosis schizophrenia second symptom could negative symptoms severely disorganized catatonic two symptoms required diagnosis schizophrenia resulting different presentations practice agreement two systems criteria puts emphasis social occupational dysfunction hand puts emphasis firstrank current proposal criteria schizophrenia recommends adding selfdisorder manuals adopted chapter heading schizophrenia spectrum psychotic disorders icd modifying schizophrenia spectrum primary psychotic definition schizophrenia remains essentially specified text revised dsmiv dsmivtr however publication apa removed subclassifications also removed subtypes removed subtype catatonic relisted psychomotor disturbance may present another major change remove importance previously given schneiders firstrank still uses listing schizophreniform disorder longer includes also recommends better distinction made current condition schizophrenia historical progress achieve clearer overall dimensional assessment included covering eight dimensions symptoms rated using scale assess severity symptom dimensions include five diagnostic criteria plus cognitive impairments mania add relevant information individual regard treatment prognosis functional outcome also enables response treatment accurately two negative symptoms avolition diminished emotional expression given prominence firstrank symptoms psychotic symptoms particularly characteristic schizophrenia put forward kurt schneider reliability diagnosis schizophrenia questioned since systematic review investigated diagnostic accuracy first rank symptoms dsmivtr contained five subclassifications schizophrenia subclassifications removed due conditions heterogeneous nature historical insignificance clinical retained previous revisions largely reasons tradition subsequently proved little defines seven subclassifications subclassifications clinical modification used medical coding reporting united states excludes postschizophrenic depression simple russian version includes additional four subclassifications schizophrenia hypochondriacal cenesthopathic childhood type atypical people schizophrenia often additional mental health problems anxiety depressive substanceuse schizophrenia occurs along obsessivecompulsive disorder ocd considerably often could explained estimated patients schizophrenia substance misuse disorder time life chances developing substance misuse disorder significantly higher among patients psychotic factors result increased range clinical presentations suggest significant etiological schizophrenia diagnosed times frequently males females onset peaking ages years males years later females show psychotic affective symptoms males less social impairment men present often negative symptoms differences likely due protective effects estrogen correlated estrogen earlyonset schizophrenia occurs ages lateonset occurs age verylateonset age estimated population schizophrenia lateonset verylate many symptoms lateonset schizophrenia similar earlyonset however individuals lateonsets likely report hallucinations sensory modalities well persecutory partition delusions hand lateonset cases less likely present formal thought disorder affective symptoms negative symptoms cognitive impairment also rarer verylate onset pathophysiology schizophrenia poorly understood multiple hypotheses put forward evidence supporting contradicting commonly supported theories dopamine hypothesis glutamate multiple genetic environment factors associated increased risk developing furthermore response treatment antipsychotic medication variable patients resistant together differences causes response treatment pathophysiology suggest schizophrenia heterogeneous etiological differences resulting terms clinical manifestations make disorder harder multiple genetic environmental factors contribute development schizophrenic phenotype distinct symptomatic sub types schizophrenia groups show distinct patterns snp variations reflecting heterogeneous nature studies also suggest genetic overlap schizophrenia psychiatric disorders autism spectrum disorders attention deficithyperactivity disorder bipolar disorder major depressive factors complicate use genetic tests diagnosis prediction onset signs disturbance present month less six months diagnosis schizophreniform disorder psychotic symptoms lasting less month may diagnosed brief psychotic disorder various conditions may classed psychotic disorder otherwise specified schizoaffective disorder diagnosed symptoms mood disorder substantially present alongside psychotic symptoms psychotic symptoms may present several mental disorders including bipolar borderline personality delusions nonbizarre also present delusional disorder social withdrawal social anxiety disorder avoidant personality disorder schizotypal personality disorder schizophrenia diagnosed symptoms mood disorder substantially present symptoms pervasive developmental disorder present unless prominent delusions hallucinations also present schizophrenia complicated obsessivecompulsive disorder ocd difficult distinguish obsessions occur ocd delusions children hallucinations must separated typical childhood urine drug screen must performed determine cause symptoms could drug intoxication druginduced psychosis example people withdrawing benzodiazepines experience severe withdrawal syndrome may last long time resemble general medical neurological examination may also needed rule medical illnesses may rarely produce psychotic schizophrenialike metabolic disturbance systemic infection syphilis hiv infection epilepsy brain lesions stroke multiple sclerosis hyperthyroidism hypothyroidism dementias alzheimers disease huntingtons disease frontotemporal dementia lewy body dementias may also associated schizophrenialike psychotic may necessary rule delirium distinguished visual hallucinations acute onset fluctuating level consciousness indicates underlying medical illness investigations generally repeated relapse unless specific medical indication possible adverse effects antipsychotic medication biomarker defined national institutes health biomarkers definitions working group biologic characteristic objectively measured evaluated indicator normal pathogenic processes response treatment biomarkers psychosis use clinical tests diagnostic prognostic predictive conversion monitoring clinical tests many benefits provide confidence diagnosis allow clinicians make better informed choices regard treatment even make possible identify subjects benefit therapy prevent transition currently biomarkers widely used clinical practice diagnosis schizophrenia brain imaging ct mri scans currently used rule brain abnormalities benefit limited structural alterations however identified schizophrenia commonly enlarged ventricles decreased grey matter volume cortex studies using functional mri also shown altered connectivity activity present last decade interest grown use machine learning automatically perform diagnosis task using brain imaging data algorithms robust distinguishing schizophrenia patients healthy subjects still perform tasks clinicians struggle differential diagnosis treatment bloodbased biomarkers obtained plasma serum samples since prevalence metabolic syndromes increased schizophrenia patients makers syndromes common targets research differences patients controls found insulin levels insulin resistance glucose effects generally small however often present subset patients results heterogeneity furthermore results often complicated metabolic side effects antipsychotic serum levels hormones typically active hypothalamic pituitary adrenal hpa axis cortisol acetylcholine also correlated symptoms progression peripheral biomarkers immune function also major target research candidates cytokines growth factors consistently identified candidates different studies variation identity direction correlation recent years markers oxidative stress epigentic methylation mrna transcription proteomic expression also targets research potential still likely single biomarker clinically useful rather biomarker assay would performed like wellperforming marker assay developed e schwarz estimates heritability schizophrenia around implies individual differences risk schizophrenia explained individual differences although many genetic variants associated schizophrenia identified effects usually small combined onto polygenic risk scores despite accounting hundreds variants explain symptom variation risk developing example genetic biomarker schizophrenia single nucleotide polymorphism gene part human leukocyte antigen hla complex g c replacement position predicts risk agranulocytosis side effect clozapine argument underlying issues would better addressed spectrum individual dimensions along everyone varies rather diagnostic category based arbitrary cutoff normal approach appears consistent research schizotypy relatively high prevalence psychotic experiences mostly nondistressing delusional beliefs among general concordance observation psychologist edgar jones psychiatrists tony david nassir ghaemi surveying existing literature delusions pointed consistency completeness definition delusion found wanting many delusions neither necessarily fixed false need involve presence incontrovertible nancy andreasen criticized current dsmiv criteria sacrificing diagnostic validity sake artificially improving reliability argues overemphasis psychosis diagnostic criteria improving diagnostic reliability ignores fundamental cognitive impairments harder assess due large variations view supported vein ming tsuang colleagues argue psychotic symptoms may common endstate variety disorders including schizophrenia rather reflection specific etiology schizophrenia warn little basis regarding dsms operational definition true construct neuropsychologist michael foster green went suggesting presence specific neurocognitive deficits may used construct phenotypes alternatives purely symptombased deficits take form reduction impairment basic psychological functions memory attention executive function problem exclusion affective components criteria schizophrenia despite ubiquity clinical settings also caused contention exclusion dsm resulted rather convoluted separate citing poor interrater reliability psychiatrists totally contested concept schizoaffective disorder separate categorical distinction mood disorders schizophrenia known kraepelinian dichotomy also challenged data genetic clinicians researchers become increasingly aware limitations current diagnostic systems calls new nosology national institute healths research domain criteria rdoc research program launched perhaps largest combined effort address need new approach classifying mental european roadmap mental health research roamer funding initiative shares many goals initiatives encourage researchers consider diagnosis dimensional instead clearcut patients healthy subjects cut across diagnostic goal develop biologically valid diagnosis defining nosology based biological measures instead symptom profiles done initial efforts area able stratify patients along psychosis continuum genetically distinct sub types based brain measures serum biomarker httpsenwikipediaorgwikidiagnosisofschizophrenia